Clinical Research Associate II; CRA II

Florida, Georgia, or Texas (Central Florida preferred for Florida-based roles)

Up to $115,000 annually; up to $118,000 for highly qualified candidates

Full-Time

Approximately 50%

November 9, 2026

We are seeking experienced Clinical Research Associate II (CRA II) professionals to support a leading biopharmaceutical organization’s clinical research programs. This is an excellent opportunity to join a collaborative, supportive clinical operations team focused on General Medicine studies.

The ideal candidate will have at least two years of clinical monitoring experience, a strong understanding of clinical trial site management, and experience conducting all types of monitoring visits. This role offers a hybrid monitoring model, a manageable site portfolio, and no on-site productivity metrics.

• Conduct on-site and remote clinical monitoring visits to ensure compliance with study protocols, Good Clinical Practice (GCP), and applicable regulatory requirements.
• Manage a portfolio of approximately 2–3 clinical study protocols and 8–10 investigative sites.
• Perform all types of monitoring visits, including site initiation, interim monitoring, and closeout visits.
• Monitor site performance, review study documentation, and ensure accurate and complete clinical trial data.
• Identify, document, and support the resolution of protocol deviations, compliance concerns, and site-level issues.
• Collaborate with clinical operations teams and investigative site personnel to support study timelines and quality objectives.
• Travel approximately 50% of the time, averaging 6–8 monitoring visits per month.

• Bachelor’s degree or equivalent four-year degree required.
• Minimum of 2 years of clinical research monitoring experience as a CRA.
• Experience supporting General Medicine clinical trials preferred.
• Demonstrated experience conducting all types of clinical monitoring visits.
• Ability to independently manage multiple protocols and a portfolio of approximately 8–10 sites.
• Strong knowledge of GCP, clinical trial regulations, monitoring practices, and clinical documentation.
• Willingness and ability to travel approximately 50% of the time.

• Sites will generally be assigned within the CRA’s home state or within a short, direct flight; neighboring states may be included.
• Monitoring will be a combination of on-site and remote visits.
• No on-site productivity metrics.
• Collaborative team environment with a strong emphasis on employee retention and support.

#LI-KP1 #LI-ONSITE